BioMarin Pharmaceutical
BMRN
#1731
Rank
NZ$21.38 B
Marketcap
NZ$110.43
Share price
-1.64%
Change (1 day)
17.96%
Change (1 year)

EPS for BioMarin Pharmaceutical (BMRN)

EPS in 2026 (TTM): NZ-$0.17

According to BioMarin Pharmaceutical's latest financial reports the company's current EPS (TTM) is NZ-$0.16. In 2025 the company made an earnings per share (EPS) of NZ$3.33 a decrease over its 2024 EPS that were of NZ$4.11.

EPS history for BioMarin Pharmaceutical from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$0.17-105.16%
2025NZ$3.33-19.11%
2024NZ$4.11152.81%
2023NZ$1.6315.79%
2022NZ$1.41-319.62%
2021NZ-$0.64-107.38%
2020NZ$8.66-3485.71%
2019NZ-$0.26-67.44%
2018NZ-$0.79-34.85%
2017NZ-$1.21-83.21%
2016NZ-$7.18263.89%
2015NZ-$1.9718.68%
2014NZ-$1.66
2012NZ-$1.74

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
NZ$3.62-2,300.59%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
NZ-$9.49 5,666.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
NZ-$0.69 322.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
NZ-$0.03656-77.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
NZ-$0.20 22.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
NZ$3.31-2,111.11%๐Ÿ‡บ๐Ÿ‡ธ USA